뒤로
Imagion Biosystems Limited(IBXXF) 가격
IBXXF 주가 차트
IBXXF 수입
Imagion Biosystems Limited
$0
0%
$0
종가: Feb 13, 16:00:00 GMT-5
$0
0%
$0
애프터마켓: Feb 13, 20:00:00 GMT-5
Earnings FAQ
IBXXF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Imagion Biosystems Limited IBXXF의 지난 분기 매출 실적은 어땠나요?
Imagion Biosystems Limited의 매출 추정치는 얼마인가요?
Imagion Biosystems Limited의 수익 품질 점수는 얼마인가요?
Imagion Biosystems Limited는 언제 수익을 보고하나요?
Imagion Biosystems Limited의 예상 수익은 얼마인가요?
Imagion Biosystems Limited은 수익 기대치를 충족했나요?
주요 통계
이전 종가
--
시가
--
일일 범위
-
52주 범위
-
거래량
--
평균 거래량
--
EPS(TTM)
--
배당수익률
--
시가총액
--
IMAGION BIOSYSTEMS LIMITED란 무엇인가요?
Imagion Biosystems Ltd. engages in the research and development of non-radioactive and safe diagnostic imaging technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-06-22. The firm is developing a non-radioactive and precision diagnostic molecular imaging technology. Its principal activity consists of nanotechnology, biotechnology, cancer diagnostics and medical imaging using magnetic resonance. The company uses bio-safe magnetic nanoparticles to detect cancer and other diseases. The firm operates through Research and Development segment. Its MagSense HER2 Imaging Agent (MSH2IA) is a first-in-class molecular imaging product candidate that is intended to detect tumors more accurately than relying solely on anatomical abnormalities seen in conventional imaging. With its tumor targeting, MSH2IA produces Magnetic resonance imaging (MRI) images that are differentiable between an abnormal lymph node and a normal node in HER2 positive breast cancer patients undergoing axillary imaging. Its PrecisionMRX products include Dextran-Coated, mPEG Coated, Oleic Acid Coated and Carboxylic Acid Functionalized.